Placement of a left ventricular assist device in a patient with dextrocardia

Southard, Robert E.; Nelson, Jonathan C.; Joyce, David L.; Thompson, Larry O.; Skrabal, Christian; Torre‐Amione, Guillermo; Youker, Keith A.; Noon, George P.; Loebe, Matthias

doi:10.1016/j.healun.2003.11.404

Cited by 5 publications

(3 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The use of LVADs in cyanotic heart disease has been limited until recently to postcardiotomy recovery in infants. The current report represents the first documented use of an axial-flow LVAD as destination therapy in an adult patient with cyanotic congenital heart disease and is the third reported case of LVAD implantation in a patient with dextrocardia [Musci 2002;Southard 2005]. Our institution previously demonstrated effective bridge-to-transplant therapy with an LVAD in a 53-year-old woman with congenitally corrected TGA and severe congestive heart failure [Gregoric 2005].…”

Section: O M M E N Tmentioning

confidence: 99%

Placement of a Continuous-Flow Ventricular Assist Device in the Failing Ventricle of an Adult Patient with Complex Cyanotic Congenital Heart Disease

Morris¹,

Gregorič²,

Cooley³

et al. 2008

The Heart Surgery Forum

View full text Add to dashboard Cite

For patients with end-stage heart failure and contraindications to transplantation, insertion of a continuous-flow left ventricular assist device (LVAD) is an effective treatment strategy. We present a case of LVAD insertion in a 46-year-old man with cyanotic complex congenital heart disease and an extensive surgical history who presented with failure of his systemic ventricle. The insertion of an LVAD in our patient restored cardiac output and improved cyanosis and native ventricular function. As the number of patients with congenital heart defects surviving to adulthood increases, destination LVAD therapy may be increasingly considered as an alternative.

show abstract

Section: O M M E N Tmentioning

confidence: 99%

Placement of a Continuous-Flow Ventricular Assist Device in the Failing Ventricle of an Adult Patient with Complex Cyanotic Congenital Heart Disease

Morris¹,

Gregorič²,

Cooley³

et al. 2008

The Heart Surgery Forum

View full text Add to dashboard Cite

show abstract

“…Prior observations have shown feasibility of paracorporeal assist device placement (Berlin Heart; Excor, Mediport, Berlin, Germany) 1 and of intra-abdominal device insertion (HeartMate I; Thoratec). 2 Although initial flow rates in the latter were reported to be satisfactory, no patient follow-up, including any abdominal wound or drive-line complication, was mentioned. 1 Other reports, on the contrary, have documented that the bulky size and the abdominal position of pulsatile assist devices may be associated with wound morbidity in young patients with end-stage congenital cardiac failure, due to the need for hosting the device in unconventional abdominal positions.…”

mentioning

confidence: 97%

“…Indeed, isolated dextrocardia, 1,2 and complex malformations, including transposition and single-ventricle lesions, 3 may eventually lead to irreversible ventricular failure, requiring long-term mechanical life support. Herein we present a case of implantation of a totally intrathoracic LVAD (HeartMate II; Thoratec Corporation, Pleasanton, CA) as bridge to transplantation in a 58-year-old patient with ischemic cardiomyopathy in situs viscerum inversus totalis.…”

mentioning

confidence: 99%